Analyst Price Targets — PRGO
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| November 6, 2025 1:46 pm | — | Canaccord Genuity | $20.00 | $14.73 | TheFly | Perrigo price target lowered to $20 from $40 at Canaccord |
| October 27, 2025 11:40 am | Keith Devas | Jefferies | $23.00 | $21.59 | TheFly | Perrigo price target lowered to $23 from $27 at Jefferies |
| August 7, 2025 1:24 pm | Susan Anderson | Canaccord Genuity | $40.00 | $22.83 | TheFly | Perrigo price target lowered to $40 from $42 at Canaccord |
| September 23, 2024 4:34 pm | Keith Devas | Jefferies | $30.00 | $27.06 | StreetInsider | Jefferies Assumes Perrigo Co. (PRGO) at Hold |
| June 13, 2024 7:36 am | Korinne Wolmeyer | Piper Sandler | $36.00 | $27.84 | StreetInsider | Perrigo Co. (PRGO) PT Lowered to $36 at Piper Sandler |
| April 8, 2024 7:01 am | Korinne Wolmeyer | Piper Sandler | $39.00 | $31.40 | StreetInsider | Perrigo Co. (PRGO) PT Raised to $39 at Piper Sandler, 'We continue to favor PRGO within our Personal Care coverage' |
| November 17, 2023 2:54 pm | Korinne Wolfmeyer | Piper Sandler | $37.00 | $30.07 | Benzinga | Personal Care Industry Poised For Growth: Analyst Initiates Coverage On These 3 Stocks |
| September 6, 2022 5:17 am | Jacob Hughes | Wells Fargo | $54.00 | $36.74 | TheFly | Perrigo upgraded to Overweight from Equal Weight at Wells Fargo |
| May 4, 2022 8:45 am | — | Raymond James | $48.00 | $32.76 | Benzinga | Raymond James Maintains Outperform on Perrigo, Lowers Price Target to $48 |
Latest News for PRGO
DUBLIN, June 30, 2026 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO) ("Perrigo"), a leading provider of consumer health products, today announced that its Board of Directors has appointed Salman Amin and Omer Gajial as independent directors, effective June 30, 2026. "We are pleased to welcome Salman and Omer to Perrigo's Board," said Orlando D.
U.S. stock futures were higher this morning, with the Nasdaq futures gaining around 200 points on Tuesday.
Perrigo Chief Executive Patrick Lockwood-Taylor has resigned after the board found his personal conduct had violated company code.
Albert A. Manzone Appointed Interim President and CEO Patrick Lockwood-Taylor Resigns as President and CEO and as a Member of the Board DUBLIN, June 8, 2026 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO) ("Perrigo" or the "Company"), a leading provider of Consumer Self-Care Products, today announced that its Board of Directors has appointed Albert A. Manzone, a member of the Company's Board, as Interim President…
Perrigo is rated Hold due to a distressed balance sheet, high leverage, and unsustainable dividend coverage. PRGO's 10.9% dividend yield is not covered by free cash flow, with near-term risk of a dividend cut unless further divestitures occur. Recent asset sales, including the Dermacosmetics business, provide short-term relief but dilute margins and highlight the need for portfolio consolidation.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.